Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR John van StekelenborgJohan ElleniusMunir Pirmohamed Special Article Open access 24 August 2019 Pages: 1393 - 1407
Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews Emanuel RaschiMatteo BianchinFabrizio De Ponti Review Article 24 September 2019 Pages: 1409 - 1422
Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review Anwar A. AlghamdiRichard N. KeersDarren M. Ashcroft Systematic Review Open access 13 August 2019 Pages: 1423 - 1436
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study Valeria BelleudiFrancesco Trottathe Italian Biosimilar Network (ItaBioNet) Original Research Article Open access 21 June 2019 Pages: 1437 - 1447
The Association between Metformin Therapy and Lactic Acidosis Isabelle H. S. KuanRuth L. SavageDaniel F. B. Wright Original Research Article 01 August 2019 Pages: 1449 - 1469
Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy Janet SultanaAndrea FontanaGianluca Trifirò Original Research Article 25 September 2019 Pages: 1471 - 1485
Data-Driven Identification of Adverse Event Reporting Patterns for Japan in VigiBase, the WHO Global Database of Individual Case Safety Reports Rika WakaoHenric TaavolaG. Niklas Norén Original Research Article Open access 26 September 2019 Pages: 1487 - 1498
Rheumatology Common Toxicity Criteria (RCTC): An Update Reflecting Real-World Use Christian M. StachVictor S. SloanDaniel E. Furst Original Research Article 06 November 2019 Pages: 1499 - 1506
Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature Brahim AzzouzAurore MorelThierry Trenque Original Research Article 09 October 2019 Pages: 1507 - 1513
Comment on: “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments” Ravi Jandhyala Letter to the Editor 24 September 2019 Pages: 1515 - 1516
Authors’ Reply to Ravi Jandhyala’s Comment on “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments” Patricia McGettiganCarla Alonso OlmoPeter G. M. Mol Letter to the Editor 24 September 2019 Pages: 1517 - 1518